1. Home
  2. GNPX vs RKDA Comparison

GNPX vs RKDA Comparison

Compare GNPX & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.02

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$3.43

Market Cap

5.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
RKDA
Founded
2009
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
5.8M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
GNPX
RKDA
Price
$2.02
$3.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
274.8K
11.4K
Earning Date
11-14-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,173,000.00
Revenue This Year
N/A
$21.31
Revenue Next Year
N/A
$28.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.31
52 Week Low
$1.99
$2.53
52 Week High
$55.00
$6.71

Technical Indicators

Market Signals
Indicator
GNPX
RKDA
Relative Strength Index (RSI) 33.69 42.08
Support Level $2.51 $3.50
Resistance Level $3.68 $3.80
Average True Range (ATR) 0.29 0.19
MACD -0.09 -0.00
Stochastic Oscillator 1.18 25.51

Price Performance

Historical Comparison
GNPX
RKDA

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

Share on Social Networks: